chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 11.0
Sex: M
Vaccine: TDAP
Symptoms: No adverse event, Product storage error
Clinical narrative: Temperature Excursion as Temperature reached: 28 F for a duration of 41 hours and 30 minutes for Adacel and it was administered post excursion with no reported adverse event; Initial information received on 19-Jul-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves 11 years old male patient and reporter reported temperature excursion as temperature reached: 28 f for a duration of 41 hours and 30 minutes for diphtheria-2/tetanus/5 AC pertussis vaccine [Adacel] and it was administered post excursion with no reported adverse event  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient was administered an unknown dose of suspect diphtheria-2/tetanus/5 AC pertussis vaccine Suspension for injection (lot 2CA23T1, expiry date- 08-DEC-2024) via unknown route in unknown administration site for prophylactic vaccination (Immunisation)  post excursion, which was exposed temperature excursion as temperature reached: 28 f for a duration of 41 hours and 30 minutes with no reported adverse event (poor quality product administered) (latency- same day).  Reportedly, Human error was not involved. temperature excursion due to Refrigerator malfunction.  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments:  US-SA-2023SA220996:01697707 (Vaxelis) US-SA-2023SA221785:related inquiry
Age: 52.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Dyspepsia, Mechanical urticaria, Nasopharyngitis
Clinical narrative: I began cold symptoms Dec. 19 with runny nose and sore throat.  By 12/23/22 I had a bad cough and took an at home COVID test that was positive.  Due to a family cruise on 12/27 (that we canceled)  I went to an urgent care facility to be tested for proof of a positive test to submit to for travel insurance.  They gave me Paxlovid and Zpac to prevent Covid pneumonia.  I tested negative 12/31  at home and I ended with rebound Covid, testing positive on 1/2/23 with another at home test.1/11/23 I was finally testing negative with the at home test. I began having itchiness that I couldn't scratch to make it go away, it felt sub-dural and moved around the skin.  It only affect my upper chest and head.  Every day I'd wake to see where my skin felt itchy.  My PCP's PA prescribed Atarax for it which helped minimally.  Eventually I saw an allergy specialist who thinks the virus brought on Dermotographism and increased the Atarax which helped the itchiness to go away. Early February, out of the blue, I started having heartburn.  I tried Prilosec 40mg 2x/day and it was still burning.  A GI specialist changed me to Pantoprazole 40 mg/2x/day and that has improved greatly.  I have GI scope and capsule implantation scheduled for 9/7/23.  IDK if this was all triggered by contracting Covid (which I don't know where I picked it up from and was the only one in the home of 3 people with it) or if they are coincidences.
Age: 52.0
Sex: F
Vaccine: COVID19-2
Symptoms: Oropharyngeal pain, Pruritus, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: I began cold symptoms Dec. 19 with runny nose and sore throat.  By 12/23/22 I had a bad cough and took an at home COVID test that was positive.  Due to a family cruise on 12/27 (that we canceled)  I went to an urgent care facility to be tested for proof of a positive test to submit to for travel insurance.  They gave me Paxlovid and Zpac to prevent Covid pneumonia.  I tested negative 12/31  at home and I ended with rebound Covid, testing positive on 1/2/23 with another at home test.1/11/23 I was finally testing negative with the at home test. I began having itchiness that I couldn't scratch to make it go away, it felt sub-dural and moved around the skin.  It only affect my upper chest and head.  Every day I'd wake to see where my skin felt itchy.  My PCP's PA prescribed Atarax for it which helped minimally.  Eventually I saw an allergy specialist who thinks the virus brought on Dermotographism and increased the Atarax which helped the itchiness to go away. Early February, out of the blue, I started having heartburn.  I tried Prilosec 40mg 2x/day and it was still burning.  A GI specialist changed me to Pantoprazole 40 mg/2x/day and that has improved greatly.  I have GI scope and capsule implantation scheduled for 9/7/23.  IDK if this was all triggered by contracting Covid (which I don't know where I picked it up from and was the only one in the home of 3 people with it) or if they are coincidences.
Age: 42.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: The pharmacist, gave patient 0.3mL rather than 0.5mL. He realized his mistake later in the day and called the patient who came back in and patient gave the remaining 0.2mL.
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Back pain, Blindness, Chest pain, Headache, Muscular weakness
Clinical narrative: Vein bulging initially with leg weakness.  Then in 2023 after having COVID, severe headaches and loss of vision, chest pain and back pain
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vein disorder
Clinical narrative: Vein bulging initially with leg weakness.  Then in 2023 after having COVID, severe headaches and loss of vision, chest pain and back pain
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Dizziness, Flushing, Hypotension
Clinical narrative: The day before the injection, I drank a lot of water. The morning of the injection, I continued drinking water. I ate a large breakfast of 2 eggs, wontons, and broccoli.  At 10:45 AM, I walked one block to the Pharmacy inside Store. After the injection, I walked around the store. 15 minutes after the injection, I felt dizzy and nearly passed out. The pharmacist brought me a chair and helped me in to it. I asked for water and drank it.  Firemen and a paramedic were called and took vital signs. All was normal except blood pressure was 90/60 which indicates low blood pressure. A fireman said I looked flushed. Later readings showed that blood pressure was back to normal. I was not allowed to walk one block home but had to call for a ride. The rest of the day, I felt better but my head hurt. Today, the next day after the injection, I am fine.
Age: 11.0
Sex: F
Vaccine: HPV9, MNQ, TDAP
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: ~ 2-3cm area of erythema Right upper arm, mild warmth
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient given expired medication, manufacturer contacted, vaccine maintained the activity necessary to protect against Covid-19 virus at time of administration.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient given expired medication, manufacturer contacted, vaccine maintained the activity necessary to protect against Covid-19 virus at time of administration.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient given expired medication, manufacturer contacted, vaccine maintained the activity necessary to protect against Covie-19 virus at time of administration.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient given expired medication, manufacturer contacted, vaccine maintained the activity necessary to protect against Covid-19 virus at time of administration.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient given expired medication, manufacturer contacted; vaccine maintained the activity necessary to protect against Covid-19 virus at time of administration.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient given expired medication, manufacturer contacted, vaccine maintained the activity necessary to protect against Covid-19 at time of administration.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient given expired medication, manufacturer contacted, vaccine maintained the activity necessary to protect against Covid-19 virus at time of administration.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient given expired medication, manufacturer contacted, vaccine maintained the activity necessary to  protect against Covid-19 virus at time of administration.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient given expired medication, manufacturer contacted, vaccine maintained the activity necessary to protect against Covid-19 virus at time of administration.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient given expired medication, manufacturer contacted, vaccine maintained the activity necessary to protect against Covid-19 virus at time of administration.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient given expired medication, manufacturer contacted, vaccine maintained the activity necessary to  protect against Covid-19 virus at time of administration.
Sex: F
Vaccine: PNC15
Symptoms: No adverse event, Product storage error
Clinical narrative: current excursion (49.1F) for 34 minutes; with two previous excursions at (35.9F) for 2 minutes and again at (35.9F) for 2 minutes; No additional AE information provided.; This spontaneous report was received from a medical assistant and referred to a 12-month-old female patient. The patient's concurrent conditions, medical history and concomitant therapies were not provided.  On an unknown date, the suspect vaccine went through temperature excursion as follows: current excursion (49.1 degree Fahrenheit [F]) for 34 minutes; with two previous excursions at (35.9 F) for 2 minutes and again at (35.9 F) for 2 minutes (Product storage error). On 03-JUN-2023, the patient was vaccinated with pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) injection, 0.5 mL, lot #W039033, expiration date: 01-OCT-2024, administered intramuscularly in left thigh for prophylaxis (strength was not provided). No adverse side effects were reported with the administration of the vaccine. ; Sender's Comments:  US-009507513-2307USA004365: US-009507513-2307USA004379: US-009507513-2307USA004509: US-009507513-2307USA004472:
Sex: M
Vaccine: PNC15
Symptoms: No adverse event, Product storage error
Clinical narrative: current excursion (49.1F) for 34 minutes; with two previous excursions at (35.9F) for 2 minutes and again at (35.9F) for 2 minutes; No additional AE information provided.; This spontaneous report was received from a medical assistant and referred to a 12-month-old male patient. The patient's concurrent conditions, medical history and concomitant therapies were not provided.  On an unknown date, the suspect vaccine went through temperature excursion as follows: current excursion (49.1 degree Fahrenheit [F]) for 34 minutes; with two previous excursions at (35.9 F) for 2 minutes and again at (35.9 F) for 2 minutes (Product storage error). On 01-JUN-2023, the patient was vaccinated with pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) injection, 0.5 mL, lot #W039033, expiration date: 01-OCT-2024, administered intramuscularly in left thigh for prophylaxis (strength was not provided). No adverse side effects were reported with the administration of the vaccine. ; Sender's Comments:  US-009507513-2307USA004472:
Age: 14.0
Sex: F
Vaccine: HPV9
Symptoms: Product storage error
Clinical narrative: No adverse event / No adverse effects; Improperly stored vaccine was administered; This spontaneous report was received from a nurse referring to a 14-year-old female patient. The patient's concurrent conditions, medical history and concomitant medications were not provided. Her historical vaccines included diphtheria vaccine toxoid (+) pertussis vaccine acellular (+) tetanus vaccine toxoid (DTAP VACCINE), influenza vaccine, Haemophilus influenzae type B (HIB) vaccine, hepatitis A vaccine (unknown manufacturer), hepatitis B vaccine (unknown manufacturer), injectible polio vaccine, meningococcal vaccine A/C/Y/W CONJ (DIP TOX) (MENACTRA), measles vaccine (+) mumps vaccine (+) rubella vaccine (unknown manufacturer), diphtheria vaccine toxoid (+) hepatitis b vaccine (+) RHBSAG (yeast) (+) pertussis vaccine acellular 3-component (+) polio vaccine inact 3v (vero) (+) tetanus vaccine toxoid (PEDIARIX), pneumococcal vaccine (unknown manufacturer) and varicella vaccine (unknown manufacturer).    On 20-JUN-2022, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered for prophylaxis (strength, dose, route of administration, anatomical location, lot # and expiry date were not provided). On 19-JUN-2023, the patient was vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered intramuscularly (IM) lot number W011455 and expiration date was reported as (11-DEC-2024)  for prophylaxis (strength and anatomical location were not provided) at a private Doctor's office/hospital.  The nurse reported that on 19-JUN-2023, hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was administered with an improperly stored (product storage error). It was presented a temperature excursion with a temperature and time frame still unknown. It was reported that vaccine temperature excursion was not viable and occurred from a digital data logger alarm believed to be due to sensory issues. Monitoring temperature with back up logger. Temperature in range, new data logger was in use. It was also reported a storage in clinical practice.  This is one of several cases by the same reporter.
Age: 0.33
Sex: U
Vaccine: RV5, UNK
Symptoms: Product storage error, Wrong product administered
Clinical narrative: No additional AE; inadvertent administration of VAXELIS and ROTATEQ after TE; This spontaneous report has been received from a consumer referring to a 4-month-old patient of unknown gender. The patient's concomitant medication, pertinent medical history, drug reactions or allergies were not provided.      On unspecified date, rotavirus vaccine, live, oral, pentavalent (ROTATEQ) and diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS), experienced 2 temperature excursions, one at 65.2 F for 9 hours and 45 minutes and another one at 32.4 F for 42 hours and 45 minutes. On 01-MAY-2023, the patient was inadvertently vaccinated with a dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally (lot number: W020326, expiration date: 17-OCT-2023) and diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) (lot number: U7217AA, expiration date: 12-NOV-2024) via unspecified route for prophylaxis (strengths, exact doses and dose numbers, were not known) after the aforementioned temperature excursions (TE) (product storage error). No symptoms were reported. At the time, no additional adverse event (AE) (no adverse event).
Sex: U
Vaccine: COVID19-2
Symptoms: Arthritis
Clinical narrative: Beginning in the end of 2022, (Current hand Ahtritis got worst)/Since Feb 2023, both hands are gradually getting worse and feeling more pain; This spontaneous case was reported by a patient and describes the occurrence of ARTHRITIS (Beginning in the end of 2022, (Current hand Ahtritis got worst)/Since Feb 2023, both hands are gradually getting worse and feeling more pain) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Concurrent medical conditions included Arthritis (Beginning in the end of 2022,) since 2022.    On 15-Jan-2023, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In February 2023, the patient experienced ARTHRITIS (Beginning in the end of 2022, (Current hand Ahtritis got worst)/Since Feb 2023, both hands are gradually getting worse and feeling more pain). At the time of the report, ARTHRITIS (Beginning in the end of 2022, (Current hand Ahtritis got worst)/Since Feb 2023, both hands are gradually getting worse and feeling more pain) had not resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant information was reported. It was reported that beginning in the end of 2022, (Current hand Arthritis got worst, and needed to visit Dr. since prior to 2022 right hand exhibited no symptoms. Since Feb 2023, both hands are gradually getting worse and feeling more pain.  No treatment information was provided. Company Comment: This is a spontaneous case concerning an elderly patient of an unknown gender, with a history of Arthritis, who experienced the non-serious unexpected, AESI event of arthritis, which occurred on the following month after a dose of mRNA-1273 vaccine, received as the fifth dose of COVID-19 vaccination schedule. The outcome of the event was reported as not recovered. The mentioned medical history remains as a confounder. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.    This case was linked to US-MODERNATX, INC.-MOD-2023-734049 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-734049:Monovalent
Age: 63.0
Sex: F
Vaccine: PNC20
Symptoms: Decreased appetite, Dehydration, Headache, Migraine, Pain in extremity
Clinical narrative: Drowsiness by 6 pm. (I slept 24 hrs in the following 32 hrs).  Soreness in left arm for 30+ hrs after vaccine administered. Migraine by 1:30 am on 21-jul.  Disappeared in 3-4 hrs but headache persisted until noon on 21-jul.  Fever between 100.5F and 101F when checked on 21-jul afternoon. Felt dehydrated even though I ensured that I had at least 2 liters of water each day.  Lack of appetite. Had to force myself to eat by 5pm on 21-Jul to fight fever.
Age: 63.0
Sex: F
Vaccine: PNC20
Symptoms: Pyrexia, Somnolence
Clinical narrative: Drowsiness by 6 pm. (I slept 24 hrs in the following 32 hrs).  Soreness in left arm for 30+ hrs after vaccine administered. Migraine by 1:30 am on 21-jul.  Disappeared in 3-4 hrs but headache persisted until noon on 21-jul.  Fever between 100.5F and 101F when checked on 21-jul afternoon. Felt dehydrated even though I ensured that I had at least 2 liters of water each day.  Lack of appetite. Had to force myself to eat by 5pm on 21-Jul to fight fever.
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site reaction, Injection site swelling, Injection site warmth
Clinical narrative: Localized reaction at the injection site consisting of pain, swelling, redness and hot to the touch. Symptoms started the evening on the same day patient received vaccine. Despite around the clock Benadryl and ibuprofen administration, redness and swelling continued to spread until patient was seen in office on 7/22/23. At the time of the office visit, swelling and redness had spread throughout 2/3 of patient's upper arm.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Blood test, Computerised tomogram, Guillain-Barre syndrome, Magnetic resonance imaging, Pulmonary function test
Clinical narrative: Guillain-Barre Syndrome  ( GBS)
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Urine analysis
Clinical narrative: Guillain-Barre Syndrome  ( GBS)
Age: 70.0
Sex: M
Vaccine: VARZOS
Symptoms: Dyspnoea, Electrocardiogram abnormal, Heart rate increased, Hyperhidrosis, Laboratory test
Clinical narrative: Patient received the vaccine at pharmacy at 3 pm 7/20/2023.  His arm became sore overnight and he noticed his heart rate was escalated at 7:30 am on 7/21/2023.  Home blood pressure monitor recorded pulse was 165 beats/min, BP was 95/85.  Patient was sweating and complained of some difficulty breathing.
Age: 70.0
Sex: M
Vaccine: VARZOS
Symptoms: Pain in extremity, Supraventricular tachycardia, Troponin I
Clinical narrative: Patient received the vaccine at pharmacy at 3 pm 7/20/2023.  His arm became sore overnight and he noticed his heart rate was escalated at 7:30 am on 7/21/2023.  Home blood pressure monitor recorded pulse was 165 beats/min, BP was 95/85.  Patient was sweating and complained of some difficulty breathing.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Dizziness, Headache
Clinical narrative: Severe and sudden onset of dizziness.  Able to get to sofa and lie down for ~5-10 minutes and dizziness went away.  Occurred two more times within 30 minutes.  Laid flat in bed both times for ~10 minutes.  Dizziness resolved after that and slight chills set in then low-grade headache a few hours later.  All symptoms resolved by ~8pm.
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Chills, Myalgia
Clinical narrative: Chills/shivering, muscle aches, joint aches
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Extra dose administered, No adverse event
Clinical narrative: The patient was given two Shingrix vaccines in 2021. However, she was given a 3rd shot on 7/20/2023 and currently there is no indication for a 3 dose of this vaccine. Currently, there are no adverse events reported so we are reporting the administration error.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Allergy test, Autoimmune disorder, Eye swelling, Food allergy, Swelling face
Clinical narrative: Started have allergic reactions to nuts , swelling of face, eyes, etc and my body was covered in hives.  This was finally diagnosed as an autoimmune disorder and I now have to get treatments (xolair injections) for continous hives every 4-6 weeks.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Started have allergic reactions to nuts , swelling of face, eyes, etc and my body was covered in hives.  This was finally diagnosed as an autoimmune disorder and I now have to get treatments (xolair injections) for continous hives every 4-6 weeks.
Age: 29.0
Sex: F
Vaccine: DTAP
Symptoms: Dizziness, Dysphonia, Glossodynia, Pain in extremity, Peripheral swelling
Clinical narrative: Voice became hoarse, tongue felt like it was being stabbed with needles, and broke out in a rash on my stomach, became very lightheaded. I still have a knot on my arm almost five days later and arm still hurts very bad. Was given a shot of 50mg of Benadryl, and symptoms subsided.
Age: 29.0
Sex: F
Vaccine: DTAP
Symptoms: Rash
Clinical narrative: Voice became hoarse, tongue felt like it was being stabbed with needles, and broke out in a rash on my stomach, became very lightheaded. I still have a knot on my arm almost five days later and arm still hurts very bad. Was given a shot of 50mg of Benadryl, and symptoms subsided.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Autoimmune thyroiditis, Condition aggravated, Dysmenorrhoea, Heavy menstrual bleeding, Menstrual disorder
Clinical narrative: After the first shot it changed the cycle of my menstrual cycle. Upon thst change I had major cramping and heavier than normal flow. After each vaccine it changed my cycle dates and the cramping and flow stayed heavy which wasn't the case many years dating back to initially having my cycle. I had a nodule on my thyroid that doctors began watching in 2020 which progressively grew in size each year in ultrasound which progresses to multifocal papillary carcinoma and hasimotos disease since having each vaccine. A few months after receiving the 3rd vaccine I developed major edema in my left leg . That I never had prior. I went to multiple vascular doctors and a cardiologist . Tested for multiple conditions and even had procedures. All conditions I never had prior to April 27, 2021
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Oedema peripheral, Papillary thyroid cancer, Thyroid mass
Clinical narrative: After the first shot it changed the cycle of my menstrual cycle. Upon thst change I had major cramping and heavier than normal flow. After each vaccine it changed my cycle dates and the cramping and flow stayed heavy which wasn't the case many years dating back to initially having my cycle. I had a nodule on my thyroid that doctors began watching in 2020 which progressively grew in size each year in ultrasound which progresses to multifocal papillary carcinoma and hasimotos disease since having each vaccine. A few months after receiving the 3rd vaccine I developed major edema in my left leg . That I never had prior. I went to multiple vascular doctors and a cardiologist . Tested for multiple conditions and even had procedures. All conditions I never had prior to April 27, 2021
Age: 20.0
Sex: F
Vaccine: VARZOS
Symptoms: Vaccination error, Viral titre
Clinical narrative: Patient presented to clinic for Varicella vaccine due to low titer.  She  was given Zoster.   Vaccine request sheet was filled out, and signed by patient and provider, but error was not caught until after clinic closed.  Patient has been notified.  No symptoms  have been reported at this time.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Amenorrhoea
Clinical narrative: I haven't had my period since I've gotten the vaccine. With that being said, I was on a couple different birth controls before, during and after getting the vaccines.. but I've now been off of all birth controls for several months now and have yet to get my period.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac failure congestive, Cardiac monitoring, Catheterisation cardiac, Echocardiogram, Electrocardiogram ambulatory
Clinical narrative: After second dose 2/26/21, 11:45 AM, Lot: EN6198, Left arm, IM, patient developed symptoms of CHF in early May 2021 correlated to decline in left ventricular systolic function.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Left ventricular dysfunction, Magnetic resonance imaging heart
Clinical narrative: After second dose 2/26/21, 11:45 AM, Lot: EN6198, Left arm, IM, patient developed symptoms of CHF in early May 2021 correlated to decline in left ventricular systolic function.
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, COVID-19, Chills, Chronic obstructive pulmonary disease, Condition aggravated
Clinical narrative: Patient is a 69 y.o. male with a history of Alcoholism, COPD, CAD, PAD, Right AKA (due to infection) Lung Cancer (s/p LUL lobectomy 2019) who presented to RMH 5/20/2023 with 4 days of fever, chills, productive cough, sore-throat and fatigue. +COVID testing   1. COVID-19: Fully Vaccinated, symptom onset 5/16/23 with recent travel (plane and cruise ship). (+) Test 5/20/23, admitted for fatigue, new oygen requirement. Treat with 10 days of Decadon, end date 5/30/23.  2. Acute on Chronic Hypoxic Respiratory Failure: due to COPD exacerbation, likely triggered by COVID. Uses home oxygen "PRN", required 2L NC continuously on admit. Steroids/nebs, resolved. 3. End Stage COPD w/Acute Exacerbation: Follows with Dr. (Pulmonology), exacerbation 2/2 COVID-19 infection. Continued steroids as above, sch nebs, 5 days of Azithromycin. Last PFT 1/2023: severe obstruction with an FEV1 of 26%. Improved at discharge. 4. Advanced PAD: with hx numerous revascularization attempts, Right AKA (2018) continued home Plavix, Statin, Cilostazole. Wheelchair bound at baseline.  5. HTN: Continued home Lisinopril, Toprol XL 6. HX of Pulmonary Embolism: Continued home Eliquis.  7. Hx of Lung Cancer: Early stage, s/p LUL lobectomy 2019, currently in surveillance.
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: Fatigue, Oropharyngeal pain, Productive cough, Pulmonary function test abnormal, Pyrexia
Clinical narrative: Patient is a 69 y.o. male with a history of Alcoholism, COPD, CAD, PAD, Right AKA (due to infection) Lung Cancer (s/p LUL lobectomy 2019) who presented to RMH 5/20/2023 with 4 days of fever, chills, productive cough, sore-throat and fatigue. +COVID testing   1. COVID-19: Fully Vaccinated, symptom onset 5/16/23 with recent travel (plane and cruise ship). (+) Test 5/20/23, admitted for fatigue, new oygen requirement. Treat with 10 days of Decadon, end date 5/30/23.  2. Acute on Chronic Hypoxic Respiratory Failure: due to COPD exacerbation, likely triggered by COVID. Uses home oxygen "PRN", required 2L NC continuously on admit. Steroids/nebs, resolved. 3. End Stage COPD w/Acute Exacerbation: Follows with Dr. (Pulmonology), exacerbation 2/2 COVID-19 infection. Continued steroids as above, sch nebs, 5 days of Azithromycin. Last PFT 1/2023: severe obstruction with an FEV1 of 26%. Improved at discharge. 4. Advanced PAD: with hx numerous revascularization attempts, Right AKA (2018) continued home Plavix, Statin, Cilostazole. Wheelchair bound at baseline.  5. HTN: Continued home Lisinopril, Toprol XL 6. HX of Pulmonary Embolism: Continued home Eliquis.  7. Hx of Lung Cancer: Early stage, s/p LUL lobectomy 2019, currently in surveillance.
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Patient is a 69 y.o. male with a history of Alcoholism, COPD, CAD, PAD, Right AKA (due to infection) Lung Cancer (s/p LUL lobectomy 2019) who presented to RMH 5/20/2023 with 4 days of fever, chills, productive cough, sore-throat and fatigue. +COVID testing   1. COVID-19: Fully Vaccinated, symptom onset 5/16/23 with recent travel (plane and cruise ship). (+) Test 5/20/23, admitted for fatigue, new oygen requirement. Treat with 10 days of Decadon, end date 5/30/23.  2. Acute on Chronic Hypoxic Respiratory Failure: due to COPD exacerbation, likely triggered by COVID. Uses home oxygen "PRN", required 2L NC continuously on admit. Steroids/nebs, resolved. 3. End Stage COPD w/Acute Exacerbation: Follows with Dr. (Pulmonology), exacerbation 2/2 COVID-19 infection. Continued steroids as above, sch nebs, 5 days of Azithromycin. Last PFT 1/2023: severe obstruction with an FEV1 of 26%. Improved at discharge. 4. Advanced PAD: with hx numerous revascularization attempts, Right AKA (2018) continued home Plavix, Statin, Cilostazole. Wheelchair bound at baseline.  5. HTN: Continued home Lisinopril, Toprol XL 6. HX of Pulmonary Embolism: Continued home Eliquis.  7. Hx of Lung Cancer: Early stage, s/p LUL lobectomy 2019, currently in surveillance.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Blood gases abnormal, Blood thyroid stimulating hormone increased, COVID-19, Chronic obstructive pulmonary disease
Clinical narrative: Patient is a 78 y.o. female patient of, DO with history of hypertension, hyperlipidemia, OSA, COPD, chronic respiratory failure on oxygen, hypothyroidism, DNR CCA as per nursing home documentations, who was brought by EMS from ECF for acute confusion, unable to provide meaningful history, last seen normal 7 PM last night, she was discovered to be confused and moaning incomprehensible words.    Acute metabolic encephalopathy Combination of hypercarbia, infection, rule out stroke ABG reviewed with hypercarbia.  With elevated baseline PCO2 in the high 60s. Continue BiPAP use at nighttime.   Evaluated by telestroke initial CT head negative. MRI brain without contrast. Aspirin 81 mg daily Lipitor 40 mg daily. PT OT SLP evaluation. Cleared for discharge per neurology Acute on chronic hypoxemic hypercarbic respiratory failure COPD with exacerbation OSA on CPAP CT chest normal lungs Albuterol MDI, Symbicort, dexamethasone Continue BiPAP use with naps and nighttime.   Sepsis, POA Sigmoid diverticulitis, acute, mild Urinary tract infection Urine culture with Proteus. Continue Zosyn Patient can continue Augmentin on discharge   Hypernatremia, likely hypovolemic On D5 water. Improved   Covid-19 Virus Infection Date of onset of symptoms: None Symptoms present on admission: Respiratory failure Date of covid positive test: May 14 Vaccination status: unvaccinated Imaging: CT lung Oxygen requirements on admission: BiPAP Current oxygen requirements: BiPAP Medical therapy: remdesivir and steroids Consultants following: Infectious disease Anticipated special isolation end date: May 24   Hypothyroidism, continue thyroxine, TSH elevated. Free T4 WNL. Increase levothyroxine to 125 mcg daily.   Hypertension, losartan on hold due to sepsis on admission.  Resume as needed.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram head normal, Computerised tomogram thorax normal, Condition aggravated, Confusional state, Culture urine positive
Clinical narrative: Patient is a 78 y.o. female patient of, DO with history of hypertension, hyperlipidemia, OSA, COPD, chronic respiratory failure on oxygen, hypothyroidism, DNR CCA as per nursing home documentations, who was brought by EMS from ECF for acute confusion, unable to provide meaningful history, last seen normal 7 PM last night, she was discovered to be confused and moaning incomprehensible words.    Acute metabolic encephalopathy Combination of hypercarbia, infection, rule out stroke ABG reviewed with hypercarbia.  With elevated baseline PCO2 in the high 60s. Continue BiPAP use at nighttime.   Evaluated by telestroke initial CT head negative. MRI brain without contrast. Aspirin 81 mg daily Lipitor 40 mg daily. PT OT SLP evaluation. Cleared for discharge per neurology Acute on chronic hypoxemic hypercarbic respiratory failure COPD with exacerbation OSA on CPAP CT chest normal lungs Albuterol MDI, Symbicort, dexamethasone Continue BiPAP use with naps and nighttime.   Sepsis, POA Sigmoid diverticulitis, acute, mild Urinary tract infection Urine culture with Proteus. Continue Zosyn Patient can continue Augmentin on discharge   Hypernatremia, likely hypovolemic On D5 water. Improved   Covid-19 Virus Infection Date of onset of symptoms: None Symptoms present on admission: Respiratory failure Date of covid positive test: May 14 Vaccination status: unvaccinated Imaging: CT lung Oxygen requirements on admission: BiPAP Current oxygen requirements: BiPAP Medical therapy: remdesivir and steroids Consultants following: Infectious disease Anticipated special isolation end date: May 24   Hypothyroidism, continue thyroxine, TSH elevated. Free T4 WNL. Increase levothyroxine to 125 mcg daily.   Hypertension, losartan on hold due to sepsis on admission.  Resume as needed.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Diverticulitis, Hypercapnia, Hypernatraemia, Hypertension, Hypothyroidism
Clinical narrative: Patient is a 78 y.o. female patient of, DO with history of hypertension, hyperlipidemia, OSA, COPD, chronic respiratory failure on oxygen, hypothyroidism, DNR CCA as per nursing home documentations, who was brought by EMS from ECF for acute confusion, unable to provide meaningful history, last seen normal 7 PM last night, she was discovered to be confused and moaning incomprehensible words.    Acute metabolic encephalopathy Combination of hypercarbia, infection, rule out stroke ABG reviewed with hypercarbia.  With elevated baseline PCO2 in the high 60s. Continue BiPAP use at nighttime.   Evaluated by telestroke initial CT head negative. MRI brain without contrast. Aspirin 81 mg daily Lipitor 40 mg daily. PT OT SLP evaluation. Cleared for discharge per neurology Acute on chronic hypoxemic hypercarbic respiratory failure COPD with exacerbation OSA on CPAP CT chest normal lungs Albuterol MDI, Symbicort, dexamethasone Continue BiPAP use with naps and nighttime.   Sepsis, POA Sigmoid diverticulitis, acute, mild Urinary tract infection Urine culture with Proteus. Continue Zosyn Patient can continue Augmentin on discharge   Hypernatremia, likely hypovolemic On D5 water. Improved   Covid-19 Virus Infection Date of onset of symptoms: None Symptoms present on admission: Respiratory failure Date of covid positive test: May 14 Vaccination status: unvaccinated Imaging: CT lung Oxygen requirements on admission: BiPAP Current oxygen requirements: BiPAP Medical therapy: remdesivir and steroids Consultants following: Infectious disease Anticipated special isolation end date: May 24   Hypothyroidism, continue thyroxine, TSH elevated. Free T4 WNL. Increase levothyroxine to 125 mcg daily.   Hypertension, losartan on hold due to sepsis on admission.  Resume as needed.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Hypovolaemia, Incoherent, Infection, Magnetic resonance imaging head, Metabolic encephalopathy
Clinical narrative: Patient is a 78 y.o. female patient of, DO with history of hypertension, hyperlipidemia, OSA, COPD, chronic respiratory failure on oxygen, hypothyroidism, DNR CCA as per nursing home documentations, who was brought by EMS from ECF for acute confusion, unable to provide meaningful history, last seen normal 7 PM last night, she was discovered to be confused and moaning incomprehensible words.    Acute metabolic encephalopathy Combination of hypercarbia, infection, rule out stroke ABG reviewed with hypercarbia.  With elevated baseline PCO2 in the high 60s. Continue BiPAP use at nighttime.   Evaluated by telestroke initial CT head negative. MRI brain without contrast. Aspirin 81 mg daily Lipitor 40 mg daily. PT OT SLP evaluation. Cleared for discharge per neurology Acute on chronic hypoxemic hypercarbic respiratory failure COPD with exacerbation OSA on CPAP CT chest normal lungs Albuterol MDI, Symbicort, dexamethasone Continue BiPAP use with naps and nighttime.   Sepsis, POA Sigmoid diverticulitis, acute, mild Urinary tract infection Urine culture with Proteus. Continue Zosyn Patient can continue Augmentin on discharge   Hypernatremia, likely hypovolemic On D5 water. Improved   Covid-19 Virus Infection Date of onset of symptoms: None Symptoms present on admission: Respiratory failure Date of covid positive test: May 14 Vaccination status: unvaccinated Imaging: CT lung Oxygen requirements on admission: BiPAP Current oxygen requirements: BiPAP Medical therapy: remdesivir and steroids Consultants following: Infectious disease Anticipated special isolation end date: May 24   Hypothyroidism, continue thyroxine, TSH elevated. Free T4 WNL. Increase levothyroxine to 125 mcg daily.   Hypertension, losartan on hold due to sepsis on admission.  Resume as needed.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Moaning, Obstructive sleep apnoea syndrome, PCO2 increased, Positive airway pressure therapy, Proteus test positive
Clinical narrative: Patient is a 78 y.o. female patient of, DO with history of hypertension, hyperlipidemia, OSA, COPD, chronic respiratory failure on oxygen, hypothyroidism, DNR CCA as per nursing home documentations, who was brought by EMS from ECF for acute confusion, unable to provide meaningful history, last seen normal 7 PM last night, she was discovered to be confused and moaning incomprehensible words.    Acute metabolic encephalopathy Combination of hypercarbia, infection, rule out stroke ABG reviewed with hypercarbia.  With elevated baseline PCO2 in the high 60s. Continue BiPAP use at nighttime.   Evaluated by telestroke initial CT head negative. MRI brain without contrast. Aspirin 81 mg daily Lipitor 40 mg daily. PT OT SLP evaluation. Cleared for discharge per neurology Acute on chronic hypoxemic hypercarbic respiratory failure COPD with exacerbation OSA on CPAP CT chest normal lungs Albuterol MDI, Symbicort, dexamethasone Continue BiPAP use with naps and nighttime.   Sepsis, POA Sigmoid diverticulitis, acute, mild Urinary tract infection Urine culture with Proteus. Continue Zosyn Patient can continue Augmentin on discharge   Hypernatremia, likely hypovolemic On D5 water. Improved   Covid-19 Virus Infection Date of onset of symptoms: None Symptoms present on admission: Respiratory failure Date of covid positive test: May 14 Vaccination status: unvaccinated Imaging: CT lung Oxygen requirements on admission: BiPAP Current oxygen requirements: BiPAP Medical therapy: remdesivir and steroids Consultants following: Infectious disease Anticipated special isolation end date: May 24   Hypothyroidism, continue thyroxine, TSH elevated. Free T4 WNL. Increase levothyroxine to 125 mcg daily.   Hypertension, losartan on hold due to sepsis on admission.  Resume as needed.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory failure, SARS-CoV-2 test positive, Sepsis, Thyroxine free normal, Urinary tract infection
Clinical narrative: Patient is a 78 y.o. female patient of, DO with history of hypertension, hyperlipidemia, OSA, COPD, chronic respiratory failure on oxygen, hypothyroidism, DNR CCA as per nursing home documentations, who was brought by EMS from ECF for acute confusion, unable to provide meaningful history, last seen normal 7 PM last night, she was discovered to be confused and moaning incomprehensible words.    Acute metabolic encephalopathy Combination of hypercarbia, infection, rule out stroke ABG reviewed with hypercarbia.  With elevated baseline PCO2 in the high 60s. Continue BiPAP use at nighttime.   Evaluated by telestroke initial CT head negative. MRI brain without contrast. Aspirin 81 mg daily Lipitor 40 mg daily. PT OT SLP evaluation. Cleared for discharge per neurology Acute on chronic hypoxemic hypercarbic respiratory failure COPD with exacerbation OSA on CPAP CT chest normal lungs Albuterol MDI, Symbicort, dexamethasone Continue BiPAP use with naps and nighttime.   Sepsis, POA Sigmoid diverticulitis, acute, mild Urinary tract infection Urine culture with Proteus. Continue Zosyn Patient can continue Augmentin on discharge   Hypernatremia, likely hypovolemic On D5 water. Improved   Covid-19 Virus Infection Date of onset of symptoms: None Symptoms present on admission: Respiratory failure Date of covid positive test: May 14 Vaccination status: unvaccinated Imaging: CT lung Oxygen requirements on admission: BiPAP Current oxygen requirements: BiPAP Medical therapy: remdesivir and steroids Consultants following: Infectious disease Anticipated special isolation end date: May 24   Hypothyroidism, continue thyroxine, TSH elevated. Free T4 WNL. Increase levothyroxine to 125 mcg daily.   Hypertension, losartan on hold due to sepsis on admission.  Resume as needed.
Age: 70.0
Sex: M
Vaccine: PNC20, TDAP, VARZOS
Symptoms: Injected limb mobility decreased, Injection site pain
Clinical narrative: left arm pain, patient claims unable to use arm - patient says they took tylenol but did not help and is going to emergency room
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Chest X-ray normal, Decreased appetite, Dehydration
Clinical narrative: Patient is a 91 y.o. male patient of a DO with history of atrial flutter, BPH, HTN, melanoma, NSVT, TIA who presented to a local Hospital with 2 to 3 days of productive cough sinus congestion and anorexia. Family felt he wasn't taking his medication and not eating.    Covid-19 Virus Infection Date of onset of symptoms: 5/17/23 Symptoms present on admission: cough, congestion Date of covid positive test: 5/19/23 Vaccination status: vaccinated Imaging: CXR no infiltrates  Oxygen requirements on admission: none Current oxygen requirements: 3 L NC, weaned down to RA at discharge Medical therapy:  ? With increase in O2 requirement, started on dexamethasone ? Scheduled Mucinex for congestio ? Scheduled Mucinex for congestion  ? 500ml fluid bolus as mildly dehydrated on admission Anticipated special isolation end date: 5/28/23 Improved over the course of hospital stay and DC home on 5 days of dexamethasone. Acute respiratory failure Did not require any O2 on admission.  But later on O2 requirement increased to 3 L NC Was able to wean down to RA prior to discharge.  Checked O2 requirement prior to discharge.  Did not qualify for oxygen   Atrial flutter Follows Dr. of Cardiology Continue home Eliquis   TIA Hyperlipidemia Continue home statin and Eliquis
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Eating disorder, Productive cough, SARS-CoV-2 test positive, Sinus congestion, Treatment noncompliance
Clinical narrative: Patient is a 91 y.o. male patient of a DO with history of atrial flutter, BPH, HTN, melanoma, NSVT, TIA who presented to a local Hospital with 2 to 3 days of productive cough sinus congestion and anorexia. Family felt he wasn't taking his medication and not eating.    Covid-19 Virus Infection Date of onset of symptoms: 5/17/23 Symptoms present on admission: cough, congestion Date of covid positive test: 5/19/23 Vaccination status: vaccinated Imaging: CXR no infiltrates  Oxygen requirements on admission: none Current oxygen requirements: 3 L NC, weaned down to RA at discharge Medical therapy:  ? With increase in O2 requirement, started on dexamethasone ? Scheduled Mucinex for congestio ? Scheduled Mucinex for congestion  ? 500ml fluid bolus as mildly dehydrated on admission Anticipated special isolation end date: 5/28/23 Improved over the course of hospital stay and DC home on 5 days of dexamethasone. Acute respiratory failure Did not require any O2 on admission.  But later on O2 requirement increased to 3 L NC Was able to wean down to RA prior to discharge.  Checked O2 requirement prior to discharge.  Did not qualify for oxygen   Atrial flutter Follows Dr. of Cardiology Continue home Eliquis   TIA Hyperlipidemia Continue home statin and Eliquis
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Asthenia, Blood osmolarity decreased, Blood sodium decreased
Clinical narrative: Patient is a 76 y.o. female patient of, MD with history of HTN, HLD, DM Type II, osteoarthritis, secondary adrenal insufficiency, RUL metastatic melanoma, asthma who presented to Hospital with generalized weakness and fatigue.   Covid-19 Virus Infection Date of onset of symptoms: 5/16/2023 Symptoms present on admission: generalized weakness, fatigue, cough, chills Date of covid positive test: 05/18/2023           Vaccination status: vaccinated Anticipated special isolation end date: 05/26/2023 Initially was on cefepime and vancomycin, discontinued on 5/19 Patient started on remdesivir on 5/19 per ID recommendations  IV remdesivir and dexamethasone in the hospital I discussed with Dr. recommendation no need for patient to finish IV remdesivir course as long as oxygen stable on room air and no symptoms Discharge home   Acute Hypoxemic Respiratory Failure CTA pulmonary arteries on 5/19/2023: negative for PE, aortic dissection. Interval decrease in size of ovoid mass in the medial suprahilar, nonspecific hilar and mediastinal adenopathy. Currently requiring room air Wean as tolerated maintaining O2 sats >90. Breathing treatment as needed  urine strep/legionella antigen negative sputum culture in progress ,MRSA DNA amplified probe.  Negative Patient initially required oxygen via nasal cannula 3 to 4 L, currently oxygen stable on room air   Malignant Melanoma of the RUL  Metastasis to brain.  Managed by Dr.   Consult oncology, pending evaluation Last treatment on 4/20/2023.   Immunotherapy induced hypophysitis Secondary adrenal insufficiency Continue Levothyroxine Solucortef increased to 30mg in AM/20mg in afternoon due to acute illness Consult endocrinology, recommendations stress dose of hydrocortisone while patient receiving IV remdesivir for COVID-19, resume outpatient dose if stable when remdesivir is discontinued   Mild hyponatremia with sodium 133 might be related to dose of hydrocortisone and poor oral intake Osmolality 283 Possibly related to poor oral intake Gentle hydration initially then discontinued Endocrinology consult, recommended stress dose of hydrocortisone while the patient on IV remdesivir   Obesity due to excessive calories Weight loss Imaging: CTA pulmonary arteries Oxygen requirements on admission: room air Current oxygen requirements: Room air Medical therapy: steroids, remdesivir Consultants following: oncology; infectious disease Anticipated special isolati